These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23470469)

  • 1. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.
    Peeters DJ; De Laere B; Van den Eynden GG; Van Laere SJ; Rothé F; Ignatiadis M; Sieuwerts AM; Lambrechts D; Rutten A; van Dam PA; Pauwels P; Peeters M; Vermeulen PB; Dirix LY
    Br J Cancer; 2013 Apr; 108(6):1358-67. PubMed ID: 23470469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
    Payne RE; Wang F; Su N; Krell J; Zebrowski A; Yagüe E; Ma XJ; Luo Y; Coombes RC
    Br J Cancer; 2012 May; 106(11):1790-7. PubMed ID: 22538972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch
    Neumann MH; Schneck H; Decker Y; Schömer S; Franken A; Endris V; Pfarr N; Weichert W; Niederacher D; Fehm T; Neubauer H
    Biotechnol Prog; 2017 Jan; 33(1):125-132. PubMed ID: 27126369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of single circulating tumour cells following long-term storage of clinical samples.
    Mesquita B; Rothwell DG; Burt DJ; Chemi F; Fernandez-Gutierrez F; Slane-Tan D; Antonello J; Carter M; Carter L; Parry M; Franklin L; Marais R; Blackhall F; Dive C; Brady G
    Mol Oncol; 2017 Dec; 11(12):1687-1697. PubMed ID: 28741788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
    Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
    Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.
    Lianidou ES; Mavroudis D; Georgoulias V
    Br J Cancer; 2013 Jun; 108(12):2426-32. PubMed ID: 23756869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
    Brouwer A; De Laere B; van Dam PJ; Peeters D; Van Haver J; Sluydts E; El Moussaoui A; Mendelaar P; Kraan J; Peeters M; Van Laere S; Dirix L
    PLoS One; 2019; 14(9):e0220906. PubMed ID: 31483799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
    Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
    Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking.
    Poudineh M; Aldridge PM; Ahmed S; Green BJ; Kermanshah L; Nguyen V; Tu C; Mohamadi RM; Nam RK; Hansen A; Sridhar SS; Finelli A; Fleshner NE; Joshua AM; Sargent EH; Kelley SO
    Nat Nanotechnol; 2017 Mar; 12(3):274-281. PubMed ID: 27870841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
    Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP
    BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
    De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
    Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of circulating tumor cells in breast cancer.
    Fina E; Callari M; Reduzzi C; D'Aiuto F; Mariani G; Generali D; Pierotti MA; Daidone MG; Cappelletti V
    Clin Chem; 2015 Jan; 61(1):278-89. PubMed ID: 25411184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.
    Flores LM; Kindelberger DW; Ligon AH; Capelletti M; Fiorentino M; Loda M; Cibas ES; Jänne PA; Krop IE
    Br J Cancer; 2010 May; 102(10):1495-502. PubMed ID: 20461092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
    Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
    Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.